Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Surg. 2010;8(4):314-7. doi: 10.1016/j.ijsu.2010.03.008. Epub 2010 Apr 7.

Synchronous gastrointestinal stromal tumors (GIST) and other primary cancers: case series of a single institution experience.

Author information

1
Department of Medical Oncology, Pontifical Catholic University of Rio Grande do Sul, São Lucas Hospital, 6690 Ipiranga av, 90610-000 Porto Alegre, Brazil. sheilasf@terra.com.br

Abstract

BACKGROUND:

Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasm affecting the gastrointestinal tract. The incidental occurrence of mesenchymal tumors and other primary tumors has not been well described in literature.

OBJECTIVE:

The aim of this study was to evaluate the clinical and pathologic features of GIST occurring synchronously with other primary tumors.

METHODS:

Forty-three patients with diagnosis of GIST treated surgically with curative intent at our institution from 1998 to 2006 were included. The patient clinical data and pathological reports were reviewed.

RESULTS:

Of the 43 patients, there were 6 (14%) cases of synchronous GIST and other primary tumors discovered as coincidental findings. The synchronous GISTs analyzed were located in the stomach (50%) and small intestine (50%), size ranging from 0.7 to 7.6 cm (median 3.35 cm). Five (83%) of the concurrent primary tumors were from gastrointestinal origin and only one (17%) patient presented with concurrent breast cancer and GIST. The synchronous GISTs immunofenotype shows positivity for CD117 and CD34 (100%), smooth-muscle actin (SMA) (67%), S100 (50%) and desmin (33%). Whereas staining for cytokeratin AE1/AE3 and PDGF were all negative. According to GIST risk category for aggressive behavior three were classified as very low, one intermediate and two high.

CONCLUSIONS:

The synchronous occurrence of GISTs and other primary neoplasm is not an uncommon entity and usually they are discovery incidentally. Epithelial tumors of the gastrointestinal tract are the most associated with concomitant GISTs. Further studies are required to clarify the molecular and genetic mechanisms of carcinogenesis and progression associating GIST and synchronous tumors.

PMID:
20380900
DOI:
10.1016/j.ijsu.2010.03.008
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center